Call Us Free: (800) 394-2767

Florida and Minnesota immunotherapy cos. to merge, move HQ to Houston

TapImmune Inc. (Nasdaq: TPIV), a Jacksonville, Florida-based developer of cancer fighting immunotherapies, is merging with Marker Therapeutics Inc., a Minnesota-based developer of similar T-cell therapies. The newly formed company will be based in Houston, due to a strategic alliance with Baylor College of Medicine.

TapImmune and Marker will each own half of the company, though the deal is still subject to the approval of TapImmune’s stockholders. Marker is privately held. The combined company will…

Source link

Leave a Reply